Business Description
Everest Medicines is a Shanghai-based biopharmaceutical company founded in 2017 that develops and sells treatments and vaccines for patients across Greater China and the wider Asia Pacific region. The company focuses on areas where effective medical options are lacking, building a portfolio that spans serious bacterial infections, kidney disease, autoimmune conditions, and cancer. Its pipeline includes both licensed and internally developed candidates at various stages of clinical testing, ranging from early phase trials to late-stage studies nearing potential approval.
